Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
9
×
Tags
fundraising
9
×
startups
biotech & health
funding
health/life sciences
venture capital
cancer
abbvie
adverse events database
amgen
amunix pharmaceuticals
anifrolumab
antitrust
apremilast
astrazeneca
autoimmune disease
azitra
belantamab mafodotin
biosimilar
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cadence neuroscience
carla grandori
celgene
chemistry
cholesterol
clinical study
crisis
deal
death
deniz kent
detroit blog main
detroit top stories
died
drug development
drugs
duchenne muscular dystrophy
What
medical
raises
million
raised
startup
device
medicine
seattle
series
company
demand
discovery
drug
health
led
people
round
treatment
abbvie’s
accelerator
according
active
age
aid
ancient
anterior
anterior’s
approval
approvals
area
aspirin
available
away
barbecuing
bark
bayer
believes
bellevue
better
billion
Language
unset
9
×
Current search:
fundraising
×
unset
×
photo
×
@techcrunch.com
4 days ago
Enveda raises $55M to combine ancient remedies with AI for drug discovery
@techcrunch.com
9 days ago
Anterior grabs $20M from NEA to expedite health insurance approvals with AI
@techcrunch.com
12 days ago
Prolific Machines, with a $55M Series B, shines ‘light’ on a better way to grow lab proteins for food and medicine
@techcrunch.com
1 year ago
Portable X-ray vision is one step closer to reality with OXOS Medical
@geekwire.com
3 years ago
KitoTech raises $3M as demand soars for its at-home no-stitch wound closure kit
@geekwire.com
3 years ago
Seattle-area medical device startup CurvaFix raises $10.7M for curved bone implant tech
@geekwire.com
4 years ago
Cadence Neuroscience raises $15M for epilepsy treatment created at Mayo Clinic
@geekwire.com
4 years ago
Fred Hutch spinout SEngine raises $5.1M to test cancer treatment drugs against a patient’s tumors
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More